Roman Zachoval

Roman Zachoval

Auto-generated profile, based on publicly available information

Roman Zachoval

Department of Urology, 3rd Faculty of Medicine, Charles University and Faculty Thomayer Hospital, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2013 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
JKJan Krhut
Jan Krhut
RZRoman Zachoval
Roman Zachoval
PSPhillip P. Smith
Phillip P. Smith
PRPeter Rosier
Peter Rosier
LVLadislav Valanský
Ladislav Valanský
PZPeter Zvara
Peter Zvara

20 August 2004 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
MMMichal Michal
Michal Michal
OHOndrej Hes
Ondrej Hes
MBMichele Bisceglia
Michele Bisceglia
RSRoderick H. W. Simpson
Roderick H. W. Simpson
DSDominic V. Spagnolo
Dominic V. Spagnolo
SSSaul Suster
Saul Suster

5 September 2001 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
ASAlexandr Svec
Alexandr Svec
OHOndrej Hes
Ondrej Hes
MMMichal Michal
Michal Michal
RZRoman Zachoval
Roman Zachoval

22 September 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
JHJan Hrbacek
Jan Hrbacek
PCPavel Cermak
Pavel Cermak
RZRoman Zachoval
Roman Zachoval
Monitoring of pathogen resistance profiles is necessary to guide empirical antibiotic therapy before culture and sensitivity results become available. The aim of this study was to describe current antibiotic resistance patterns of five most frequent causative uropathogens in a Department of Urology of a tertiary referral centre in Central Europe over a period of nine years. The Hospital Department of Clinical Microbiology database was used to extract data on all positive urine samples from inpatients in the Department of Urology between 2011 and 2019. Numbers of susceptible and resistant isolates per year were calculated for five most frequent uropathogens: Escherichia coli, Enterococcus spp., Klebsiella spp., Pseudomonas aeruginosa, and Proteus spp. Antimicrobial agents selected for the survey included: ampicillin, amoxicillin/clavulanic acid, piperacillin/tazobactam; cefuroxime, cefotaxime, ceftazidime and cefepime; ciprofloxacin and ofloxacin; gentamicin and amikacin; ertapenem, meropenem and imipenem; trimethoprim-sulfamethoxazole (co-trimoxazole), nitrofurantoin, colistin, and vancomycin. High resistance rates of Gram-negative uropathogens were demonstrated to most common antimicrobials, with statistically significant increasing or decreasing trends in some cases. No carbapenem-resistant Enterobacteriaceae were isolated. Vancomycin-resistant Enterococcus spp. strains were rare in our population.

31 March 2018 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
JKJan Krhut
Jan Krhut
VBVladimír Borovička
Vladimír Borovička
KBKarolína Bílková
Karolína Bílková
RSRadek Sýkora
Radek Sýkora
DMDavid Míka
David Míka
RZRoman Zachoval
Roman Zachoval

21 November 2016 in BJU International
Verified
Journal Article
Closed access
PDF file
AFAlexander Friedl
Alexander Friedl
SMSandra Mühlstädt
Sandra Mühlstädt
RZRoman Zachoval
Roman Zachoval
AGAlessandro Giammò
Alessandro Giammò
DKDanijel Kivaranovic
Danijel Kivaranovic
CBClemens Brössner
Clemens Brössner